Huiqing Yu

546 total citations
29 papers, 299 citations indexed

About

Huiqing Yu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Huiqing Yu has authored 29 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Huiqing Yu's work include Lung Cancer Treatments and Mutations (6 papers), Palliative Care and End-of-Life Issues (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Huiqing Yu is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Palliative Care and End-of-Life Issues (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Huiqing Yu collaborates with scholars based in China, United States and Canada. Huiqing Yu's co-authors include Ling Tian, Shihong Liu, Junhui Qian, Dan Zhang, Xiaoping Zeng, Bei Liu, Ran Liu, Mengting Chen, Xiao Ma and Xiaohong Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Huiqing Yu

27 papers receiving 296 citations

Peers

Huiqing Yu
Yixi Wu China
Joana Cerveira United Kingdom
Jessica O’Rear United States
Yaxin Chen China
Michaela Welch United States
Qi Song China
Lifang Huang China
E Cortés Spain
Pengjun Jiang China
Xianggui Wang China
Yixi Wu China
Huiqing Yu
Citations per year, relative to Huiqing Yu Huiqing Yu (= 1×) peers Yixi Wu

Countries citing papers authored by Huiqing Yu

Since Specialization
Citations

This map shows the geographic impact of Huiqing Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiqing Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiqing Yu more than expected).

Fields of papers citing papers by Huiqing Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiqing Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiqing Yu. The network helps show where Huiqing Yu may publish in the future.

Co-authorship network of co-authors of Huiqing Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Huiqing Yu. A scholar is included among the top collaborators of Huiqing Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiqing Yu. Huiqing Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Yang, Chao Zhang, Haibo Liu, et al.. (2025). ER-resident CCDC134 safeguards TLR4 maturation by maintaining gp96 stability. Proceedings of the National Academy of Sciences. 122(34). e2512154122–e2512154122. 1 indexed citations
2.
3.
Liu, Shihong, Li Wang, Fengxiang Lv, et al.. (2024). Hydrogel based flexible wearable sweat sensor for SERS-AI monitoring treatment effect of lung cancer. Sensors and Actuators B Chemical. 427. 137155–137155. 17 indexed citations
4.
Chen, Mengting, et al.. (2024). Knowledge, attitudes, and current practices toward lung cancer palliative care management in China: a national survey. Frontiers in Oncology. 14. 1382496–1382496. 2 indexed citations
5.
Yu, Huiqing, Mengting Chen, & Junhui Zhang. (2024). Nutritional assessment for 891 patients with common cancer in a cancer hospital of southwest China.. Journal of Clinical Oncology. 42(16_suppl). e23280–e23280.
6.
7.
Zhang, Can, Hongmei Li, Min Jiang, et al.. (2023). Hypoxic microenvironment promotes dermal fibroblast migration and proliferation via a BNIP3 ‐autophagy pathway. FEBS Journal. 291(2). 358–375. 3 indexed citations
8.
Chen, Mengting, Huiqing Yu, Yang Hong, et al.. (2023). Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China. Frontiers in Oncology. 13. 1184961–1184961. 6 indexed citations
9.
10.
11.
Chen, Mengting, Huiqing Yu, Shao‐Yi Huang, et al.. (2023). JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China. Frontiers in Oncology. 13. 1155592–1155592. 14 indexed citations
12.
Yu, Huiqing, et al.. (2022). A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer. BMC Palliative Care. 21(1). 81–81. 16 indexed citations
13.
Yu, Huiqing, Gang Li, & Hong‐Xiang Lou. (2022). Isolation, Biosynthesis, and Biological Activity of Polycyclic Xanthones From Actinomycetes. Frontiers in Microbiology. 13. 922089–922089. 8 indexed citations
14.
Liu, Bei, Huiqing Yu, Xiaoping Zeng, et al.. (2021). Lung cancer detection via breath by electronic nose enhanced with a sparse group feature selection approach. Sensors and Actuators B Chemical. 339. 129896–129896. 61 indexed citations
15.
Liu, Bei, Xiaoping Zeng, Huiqing Yu, et al.. (2021). Sparse Unidirectional Domain Adaptation Algorithm for Instrumental Variation Correction of Electronic Nose Applied to Lung Cancer Detection. IEEE Sensors Journal. 21(15). 17025–17039. 13 indexed citations
16.
Yu, Huiqing, et al.. (2021). Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC via Mediation of PI3K/Akt Signaling Pathway. Frontiers in Oncology. 11. 620213–620213. 17 indexed citations
17.
Fang, Jian, Yongqian Shu, Dan Wang, et al.. (2019). OA01.08 A Phase I Study to Evaluate Safety and Antitumor Activity of BPI-7711 in EGFRM+/T790M+ Advanced or Recurrent NSCLC Patients. Journal of Thoracic Oncology. 14(11). S1126–S1127. 2 indexed citations
18.
Li, Yan, Zhijuan Wu, Dairong Li, et al.. (2017). Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells. Oncology Letters. 14(4). 3989–3996. 7 indexed citations
19.
Li, Yan, Zhijuan Wu, Lulu Wang, et al.. (2017). Silencing of ATM expression by siRNA technique contributes to glioma stem cell radiosensitivity in vitro and in vivo. Oncology Reports. 38(1). 325–335. 15 indexed citations
20.
Soria, J.C., Lecia V. Sequist, Heather A. Wakelee, et al.. (2014). 10LBA Interim phase 2 results of study CO-1686-008: A phase 1/2 study of the irreversible, mutant selective, EGFR inhibitor rociletinib (CO-1686) in patients with advanced non small cell lung cancer. European Journal of Cancer. 50. 199–199. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yixi Wu Breakdown of academic impact, for papers by Joana Cerveira Breakdown of academic impact, for papers by Jessica O’Rear Breakdown of academic impact, for papers by Yaxin Chen Breakdown of academic impact, for papers by Michaela Welch Breakdown of academic impact, for papers by Qi Song Breakdown of academic impact, for papers by Lifang Huang Breakdown of academic impact, for papers by E Cortés Breakdown of academic impact, for papers by Pengjun Jiang Breakdown of academic impact, for papers by Xianggui Wang
Rankless by CCL
2026